文献速递神经介入DSAMRCT

不同治疗方式下未破裂颅内椎基底动脉夹层动脉瘤伴脑干压迫的转归

The Fate of Unruptured Intracranial Vertebrobasilar Dissecting Aneurysm with Brain Stem Compression According to Different Treatment Modalities.
PubMed 文献 · AJNR Am J Neuroradiol · 2019-10-10

回顾性纳入2009年1月至2017年12月28例未破裂颅内椎基底动脉夹层动脉瘤伴脑干压迫患者,治疗方式为观察6例、支架辅助弹簧圈栓塞9例、载瘤动脉闭塞6例、血流导向装置7例。载瘤动脉闭塞与血流导向装置组的动脉瘤体积缩小率较高且mRS评分改善,观察组与支架辅助栓塞组需额外治疗及mRS恶化比例较高。

要点

  • 载瘤动脉闭塞组动脉瘤体积缩小率最高(26.7±32.1%),血流导向装置组次之(14.1%±28.7%)。
  • 观察组需额外治疗4/6(66.7%),支架辅助栓塞组3/9(33.3%;P=.017)。
  • 血流导向装置组mRS改善6/7(85.7%),无mRS恶化(0/7,0%)。

核心结论

  • 治疗颅内椎基底动脉夹层动脉瘤伴脑干压迫时,应考虑载瘤动脉闭塞与血流导向装置以缩小动脉瘤体积并改善mRS评分。

研究设计与样本

  • 回顾性队列研究,纳入2009年1月至2017年12月共28例未破裂颅内椎基底动脉夹层动脉瘤伴脑干压迫患者。
  • 治疗方式:观察6例、支架辅助弹簧圈栓塞9例、载瘤动脉闭塞6例、血流导向装置7例。
  • 数据来自回顾性病历回顾,包括基线特征、动脉瘤大小变化、再治疗率、卒中发生及mRS评分变化。

关键影像表现/征象

  • 夹层动脉瘤初始大小:血流导向装置组最大(22.5±7.7 mm),其次为载瘤动脉闭塞组(20.3±8.4 mm)、支架辅助弹簧圈栓塞组(11.7±2.2 mm)、观察组(17.8±5.5 mm;P=.01)。
  • 动脉瘤体积缩小率:载瘤动脉闭塞组最高(26.7±32.1%),其次为血流导向装置组(14.1%±28.7%)、支架辅助弹簧圈栓塞组(-17.9±30.3%)、观察组(-31.5±30.8%;P=.007)。

临床应用与阅片要点

  • 随访中需关注动脉瘤大小变化、再治疗率、卒中发生及mRS评分变化。
  • 作者认为,治疗颅内椎基底动脉夹层动脉瘤伴脑干压迫时,应考虑载瘤动脉闭塞与血流导向装置以缩小动脉瘤体积并改善mRS评分。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Unruptured intracranial vertebrobasilar dissecting aneurysms with brain stem compression are difficult to treat. In the present study, the clinical and radiologic outcomes of unruptured intracranial vertebrobasilar dissecting aneurysms with brain stem compression based on different treatment modalities were evaluated.

MATERIALS AND METHODS: This study included 28 patients with unruptured intracranial vertebrobasilar dissecting aneurysms with brain stem compression treated from January 2009 to December 2017. Treatment methods were observation (n = 6), stent-assisted coil embolization (n = 9), parent artery occlusion (n = 6), and flow diversion (n = 7). The data of baseline characteristics, change of aneurysm size, retreatment rate, stroke occurrence, and alteration of the mRS score were obtained from retrospective chart review.

RESULTS: The initial size of dissecting aneurysms was largest in the flow diversion group (22.5 ± 7.7 mm), followed by parent artery occlusion (20.3 ± 8.4 mm), stent-assisted coil embolization (11.7 ± 2.2 mm), and observation (17.8 ± 5.5 mm; P = .01) groups. The reduction rate of aneurysm size was highest in the parent artery occlusion group (26.7 ± 32.1%), followed by flow diversion (14.1% ± 28.7%), stent-assisted coil embolization (-17.9 ± 30.3%), and observation (-31.5 ± 30.8%; P = .007) groups. Additional treatment was needed in the observation (4/6, 66.7%) and stent-assisted coil embolization (3/9, 33.3%; P = .017) groups. Improvement of the mRS score on follow-up was observed in the flow diversion (6/7, 85.7%) and parent artery occlusion (4/6, 66.7%) groups but not in the stent-assisted coil embolization and observation groups. A worsened mRS score was most common in the observation group (4/6, 66.7%), followed by stent-assisted coil embolization (3/9, 33.3%), parent artery occlusion (2/6, 33.3%), and flow diversion (0/7, 0%) groups.

CONCLUSIONS: When treating intracranial vertebrobasilar dissecting aneurysms with brain stem compression, parent artery occlusion and flow diversion should be considered to reduce aneurysm size and improve the mRS score.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Cho DY, Kim BS, Choi JH, et al. The Fate of Unruptured Intracranial Vertebrobasilar Dissecting Aneurysm with Brain Stem Compression According to Different Treatment Modalities. AJNR Am J Neuroradiol. 2019. PMID: 31601577. doi:10.3174/ajnr.A6252

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。